INAMED CORP

INAMED CORP, tracking under CIK 109831, is a medical technology manufacturer historically associated with SIC 3841, Medical Instruments and Supplies, and it sells implants and aesthetic devices to surgeons, dermatology clinics, and hospital systems focused on reconstructive and cosmetic interventions. The company’s portfolio spans injectable fillers, soft-tissue augmentation implants, and deliverables designed to support minimally invasive aesthetic procedures, positioning it squarely in the healthcare provider and surgical practice ecosystem. Revenue depends both on elective-use adoption and reimbursement trends, so it must navigate FDA device clearances, post-market surveillance expectations, and global regulatory harmonization to keep products on shelves. Material risks include FDA or European regulatory delays, litigation from device outcomes, supply-chain sensitivity for medical-grade materials, and the need to sustain R&D amidst pricing pressures from larger rivals. Latest filing: unknown, which keeps investors reliant on future disclosures for clarity, so align with live monitoring habits. View live SEC filings on Earnings Feed.

Source: Earnings Feed research · last updated 11/24/2025